KLRK1 and neoplasm: Targeting MDSCs with NKG2D.ζ-NK cells inhibits the function of MDSCs and improves the anti-tumor role of tumor-directed chimeric antigen receptor (CAR)-modified T cells (CAR-T) in a xenograft tumor model (59).